LPCN
Price
$3.18
Change
-$0.07 (-2.15%)
Updated
Jun 30, 11:52 AM (EDT)
Capitalization
17.6M
ZNTL
Price
$1.18
Change
-$0.08 (-6.35%)
Updated
Jun 27 closing price
Capitalization
84.9M
38 days until earnings call
Interact to see
Advertisement

LPCN vs ZNTL

Header iconLPCN vs ZNTL Comparison
Open Charts LPCN vs ZNTLBanner chart's image
Lipocine
Price$3.18
Change-$0.07 (-2.15%)
Volume$300
Capitalization17.6M
Zentalis Pharmaceuticals
Price$1.18
Change-$0.08 (-6.35%)
Volume$8.83M
Capitalization84.9M
LPCN vs ZNTL Comparison Chart in %
Loading...
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPCN vs. ZNTL commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPCN is a Buy and ZNTL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (LPCN: $3.25 vs. ZNTL: $1.18)
Brand notoriety: LPCN and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPCN: 64% vs. ZNTL: 919%
Market capitalization -- LPCN: $17.6M vs. ZNTL: $84.9M
LPCN [@Biotechnology] is valued at $17.6M. ZNTL’s [@Biotechnology] market capitalization is $84.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPCN’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • LPCN’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both LPCN and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPCN’s TA Score shows that 4 TA indicator(s) are bullish while ZNTL’s TA Score has 2 bullish TA indicator(s).

  • LPCN’s TA Score: 4 bullish, 3 bearish.
  • ZNTL’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, LPCN is a better buy in the short-term than ZNTL.

Price Growth

LPCN (@Biotechnology) experienced а -1.52% price change this week, while ZNTL (@Biotechnology) price change was -9.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.66%. For the same industry, the average monthly price growth was +32.94%, and the average quarterly price growth was +6.79%.

Reported Earning Dates

ZNTL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZNTL($84.9M) has a higher market cap than LPCN($17.6M). LPCN YTD gains are higher at: -33.402 vs. ZNTL (-61.056). LPCN has higher annual earnings (EBITDA): -6.42M vs. ZNTL (-199.29M). ZNTL has more cash in the bank: 332M vs. LPCN (19.7M). LPCN has less debt than ZNTL: LPCN (1.48M) vs ZNTL (38.7M). ZNTL has higher revenues than LPCN: ZNTL (26.9M) vs LPCN (3.68M).
LPCNZNTLLPCN / ZNTL
Capitalization17.6M84.9M21%
EBITDA-6.42M-199.29M3%
Gain YTD-33.402-61.05655%
P/E RatioN/AN/A-
Revenue3.68M26.9M14%
Total Cash19.7M332M6%
Total Debt1.48M38.7M4%
FUNDAMENTALS RATINGS
LPCN: Fundamental Ratings
LPCN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LPCNZNTL
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLFS21.490.12
+0.56%
BioLife Solutions
FTV71.600.38
+0.53%
Fortive Corp
SPKL10.910.03
+0.27%
Spark I Acquisition Corp
SWTX46.98-0.01
-0.02%
SpringWorks Therapeutics
CING4.05-0.05
-1.22%
Cingulate Inc

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with ZNTL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then ZNTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
+0.93%
ZNTL - LPCN
35%
Loosely correlated
-6.35%
FGHQF - LPCN
28%
Poorly correlated
N/A
PRME - LPCN
26%
Poorly correlated
-8.68%
ELDN - LPCN
25%
Poorly correlated
-1.82%
RZLT - LPCN
25%
Poorly correlated
+0.93%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
-6.35%
IDYA - ZNTL
47%
Loosely correlated
-4.13%
IMNM - ZNTL
46%
Loosely correlated
-0.23%
CRBU - ZNTL
46%
Loosely correlated
-6.67%
NGNE - ZNTL
45%
Loosely correlated
-2.47%
IPSC - ZNTL
45%
Loosely correlated
-5.74%
More